US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Eurocommercial Properties NV (ECMPM) 銘柄情報

Eurocommercial Properties NV (ECMPM)

27.75

0.00

(0.00%)

終了 6月13日 12:30AM

Eurocommercial Properties NV (ECMPM) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

27.75

( - )

買値

27.50

売値

28.15

出来高

0.00

0.00 日の範囲 0.00

24.70 52 週間の範囲 29.60

時価総額

前日終値

27.75

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

67,322 €

発行済株式数

54,679,475

配当利回り

(6.48%)

PER

11.72

1 株当たり利益 (EPS)

2.31

歳入

285.96M

純利益

126.7M

Eurocommercial Properties N.V. is a Euronext-quoted property investment company and one of Europe’s shopping centre specialists. Founded in 1991, Eurocommercial currently owns and operates 24 shopping centres in Belgium, France, Italy, and Sweden with total assets of 4 billion euros. Eurocommercial ... Eurocommercial Properties N.V. is a Euronext-quoted property investment company and one of Europe’s shopping centre specialists. Founded in 1991, Eurocommercial currently owns and operates 24 shopping centres in Belgium, France, Italy, and Sweden with total assets of 4 billion euros. Eurocommercial Properties N.V. was incorporated in Netherlands. 詳細を表示

セクター

Real Estate

業界

Reits

ウェブサイト

www.eurocommercialproperties.com

本社

Amsterdam, Netherlands

設立

-

Eurocommercial Properties NV is listed in the Real Estate sector of the イタリア証券取引所 with ticker ECMPM. The last closing price for Eurocommercial Propertie... was 27.75 €. Over the last year, Eurocommercial Propertie... shares have traded in a share price range of 24.70 € to 29.60 €.

Eurocommercial Propertie... currently has 54,679,475 shares in issue. The market capitalisation of Eurocommercial Propertie... is 1.52 € billion. Eurocommercial Propertie... has a price to earnings ratio (PE ratio) of 11.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.55	2.02205882353	27.2	27.75	26.7	118	27.33612521	DE
4	0.5	1.83486238532	27.25	29.6	26.7	361	28.84206074	DE
12	1.55	5.91603053435	26.2	29.6	25	303	27.69747419	DE
26	2.05	7.9766536965	25.7	29.6	24.7	598	26.48026277	DE
52	2.05	7.9766536965	25.7	29.6	24.7	503	26.50426339	DE
156	5.45	24.4394618834	22.3	29.6	19.35	378	24.76552589	DE
260	5.89	26.9441903019	21.86	29.6	19.35	382	24.65472633	DE

ECMPM - Frequently Asked Questions (FAQ)

What is the current Eurocommercial Properties NV share price?

The current share price of Eurocommercial Properties NV is 27.75 €

How many Eurocommercial Properties NV shares are in issue?

Eurocommercial Properties NV has 54,679,475 shares in issue

What is the market cap of Eurocommercial Properties NV?

The market capitalisation of Eurocommercial Properties NV is EUR 1.52B

What is the 1 year trading range for Eurocommercial Properties NV share price?

Eurocommercial Properties NV has traded in the range of 24.70 € to 29.60 € during the past year

What is the PE ratio of Eurocommercial Properties NV?

The price to earnings ratio of Eurocommercial Properties NV is 11.72

What is the cash to sales ratio of Eurocommercial Properties NV?

The cash to sales ratio of Eurocommercial Properties NV is 5.18

What is the registered address of Eurocommercial Properties NV?

The registered address for Eurocommercial Properties NV is De Boelelaan 7, Amsterdam, Noord-Holland, 1083 HJ

What is the Eurocommercial Properties NV website address?

The website address for Eurocommercial Properties NV is www.eurocommercialproperties.com

Which industry sector does Eurocommercial Properties NV operate in?

Eurocommercial Properties NV operates in the REITs sector

81vette

81vette 9分前

I understand now,merger had a 20 day mandatory waiting period,it ended and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good ,I bet updates/PRs will be often now.
We made it thru the

RockQQ

RockQQ 10分前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 12分前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 13分前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 22分前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 23分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 27分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 28分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 30分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 34分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 37分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 44分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 45分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 45分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 46分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 47分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 49分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 49分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 53分前

Just give me $1.50

Just give me $1.50 53分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 58分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 1時間前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Eurocommercial Propertie...

Carlyle Group Inc The

3x Long Coupang

2.75% Grn Trns Nts 20/12...

Global X Uranium UCITS E...

Prudential Financial

AfterNext HealthTech Acq...

Ci Canadian Investment C...

Clean Seas Seafood

Caja De Ahorro Del Medit...

Impel Pharmaceuticals

Piper Sandler Companies

Banco Bilbao Vizcaya Arg...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。